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Summer Meeting, 14–17 July 2014, Carbohydrates in health: friends or foes
The effect of in vitro fermentation of oats (Avena sativa) and barley
(Hordeum vulgare) on the faecal gut microbiota
A. J. Chappell1, F. Thies1, P. Martin2, H.J. Flint1 and K. P. Scott1
1Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB25 9SB and 2Agronomy Institute,
Orkney College, University of the Highlands and Islands, Orkney, KW15 1LX
Diets high in whole grain cereals may reduce the risk of cardiovascular disease (CVD) and colorectal cancer1−2. Mixed link β-glucans
found within oats (Avena sativa) and barley (Hordeum vulgare) could be partly responsible for this. The cholesterol lowering effect of
oat β-glucans currently has several endorsed health claims including the U.S Food and Drug Administration (FDA) and the European
Food Safety Authority3–4. β-glucans may also reduce the risk of disease by increasing satiety, reducing body mass index, lowering
blood glucose and increasing stool transit time. Little is known about how β-glucans inﬂuence the gut microbiota. However, the de-
velopment of culture independent techniques using 16S rRNA-targeting arrays have demonstrated the importance of bacterial com-
munity composition, and bacterial metabolites, in health and disease. Prebiotics are deﬁned as non-digestible plant derived
carbohydrates that act as fermentation substrates that stimulate the preferential growth and activity of microbial species that confer
health beneﬁts to the host. Understanding how prebiotics the inﬂuence gut microbiota is a growing area of interest5.
Here we investigated the effects of different cultivars of oats and barley on microbial activity and composition. Firstly a batch cul-
ture experiment was performed using faecal inocula from four different volunteers. Five cultivars were compared; pH and short chain
fatty acid (SCFA) concentrations were measured at 0, 24, and 48 h. After 48 h, pH signiﬁcantly decreased by at least 1·1 unit in all
incubations, while SCFA concentrations signiﬁcantly increased (p< 0·05). No difference was observed between incubations. This was
followed by a continuous ﬂow fermentor, where two cultivars were compared. The fermentor produced a different SCFA proﬁle
compared with the batch experiment. Maintenance of the pH at 5·8 and the continuous ﬂow could have contributed to this.
Microbial analysis of the fermentor samples by ﬂuorescence in situ hybridisation (FISH) found a shift towards Bacteroides genus
and a reduction in Firmicutes and Actinobacteria. The bacterial composition and SCFA ratios were very similar between the oats and
barley cultivars. However, signiﬁcantly more butyrate was produced compared to the high carbohydrate control. As butyrate may
have anti-carcinogenic properties, increasing consumption of oats and barley could potentially provide important health beneﬁts.
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Fermentor Short Chain Fatty Acids at Day 15
Concentrations mmol/l Percentage of Total (%)
Acetate Propionate Butyrate Lactate Acetate Propionate Butyrate Lactate
Belinda Oats 29·29a 12·36a 9·41a 3·40a 46·2a 19·5a 14·8a 5·4a
Bere Barley 24·44a 14·21a 11·23a 5·88a 37·6b 21·9a 17·3a 9·1a
Control 43·64b 41·24b 4·19b 1·42a 46·6a 44·1b 4·50b 1·5a
Control was a high mixed carbohydrate medium
Different letters within columns denote signiﬁcant difference (p< 0·05)
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